EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
EyePoint Pharmaceuticals Inc
Inventory
EyePoint Pharmaceuticals Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
|
Inventory
$4.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Inventory
$11.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Inventory
$3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
6%
|
|
Pfizer Inc
NYSE:PFE
|
Inventory
$10.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Merck & Co Inc
NYSE:MRK
|
Inventory
$6.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Inventory
$6.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
See Also
What is EyePoint Pharmaceuticals Inc's Inventory?
Inventory
4.3m
USD
Based on the financial report for Mar 31, 2024, EyePoint Pharmaceuticals Inc's Inventory amounts to 4.3m USD.
What is EyePoint Pharmaceuticals Inc's Inventory growth rate?
Inventory CAGR 5Y
36%
Over the last year, the Inventory growth was 4%. The average annual Inventory growth rates for EyePoint Pharmaceuticals Inc have been -9% over the past three years , 36% over the past five years .